AG
OXFD

Advisor Group’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Advisor Group’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$146K Sell
8,838
-44
-0.5% -$713 ﹤0.01% 2640
2019
Q3 		$148K Buy
8,882
+2,010
+29% +$27.8K ﹤0.01% 2569
2019
Q2 		$95K Buy
6,872
+300
+5% +$4.59K ﹤0.01% 2907
2019
Q1 		$113K Buy
+6,572
New +$104K ﹤0.01% 2763

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Advisor Group's OXFD Position: Q4 2019 in Review

Advisor Group reduced its Oxford Immunotec Global PLC Ordinary Shares (OXFD) stake by 0.5% in Q4 2019, selling an estimated $713 and leaving 8,838 shares worth $146K. The position accounts for ﹤0.01% of the portfolio, ranked #2640.

Advisor Group first reported a position in OXFD in Q1 2019 and has held it in 4 quarters since. The position peaked at $148K in Q3 2019. 68 funds tracked by Wall St. Rank hold OXFD as of Q4 2019.

  • Advisor Group held 8,838 shares of Oxford Immunotec Global PLC Ordinary Shares worth $146K as of Q4 2019.
  • Advisor Group sold 44 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2019, an estimated $713.
  • Oxford Immunotec Global PLC Ordinary Shares made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2640 holding.
  • Advisor Group first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2019 and has held it in 4 quarters since.
  • Advisor Group's Oxford Immunotec Global PLC Ordinary Shares position peaked at $148K in Q3 2019.
  • 68 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.